title: Natalizumab-associated complication? First case of peripheral T cell lymphoma.
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Schowinsky
authors.forename: John
authors.initials: J
authors.lastname: Corboy
authors.forename: Timothy
authors.initials: T
authors.lastname: Vollmer
authors.forename: B K
authors.initials: BK
authors.lastname: Kleinschmidt-DeMasters
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D017252:CD3 Complex / Q000378:metabolism; D005260:Female; D006801:Humans; D019394:Ki-67 Antigen / Q000378:metabolism; D016411:Lymphoma, T-Cell, Peripheral / Q000139:chemically induced* / Q000175:diagnosis; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D000069442:Natalizumab; D014057:Tomography, X-Ray Computed
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D017252:CD3 Complex; D019394:Ki-67 Antigen; D000069442:Natalizumab